Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact
August 22nd, 2007 1:00 – 2:00pm EDT
Better Understanding Pharma and Biotech Industry Trends through the Use of Performance Management (PM)
  • George Foldes, Senior Business Analyst, Aspreva PharmaceuticalsLearn More
  • Christopher-Paul Milne, D.V.M., M.P.H., J.D., Associate Director, Tufts Center For The Study Of Drug Development
  • Tim Knutson, Area Manager, Applix
  • Better Understanding Industry Trends and Drivers in the Pharma and Biotech Industries through the use of Performance Management (PM) Technology

    Join this webinar to learn how to get better visibility into your data and improve your understanding of industry trends and drivers to improve overall company ROI.

    Key learning points include:

    • Product costing and overhead cost controlling
    • Financial reporting and profitability analysis
    • Compliance and validation
    • Project management
    • Document management
    • Clinical trial supply management

    VPs, Directors, Managers of:

    • Finance
    • IT
    • Reporting
    • Internal Control and Audit
    • Compliance
    • Accounting
    • Corporate Governance

    Within the Pharma and Biotech Industries 

    • CFOs
    • CAOs
    • CIOs
    • Controllers

    Applix is a global leader in business analytics solutions that enable continuous strategic planning, management and monitoring of performance across the financial, operational, sales, marketing, and human resources functions within the enterprise. Applix solutions take business performance management to a new dimension of responsiveness and agility with a fast, flexible, and unified environment for finance and business users to perform strategic self-service planning, budgeting, forecasting, analytics, and reporting. Applix is easily integrated into your existing environment, supporting standards and key technology platforms. Applix is highly scalable, supporting thousands of users and is best to drive results for your company's growth strategy, and prepare for whatever the regulators, the markets or the global economy throw at you next.

    Applix and its global network of partners help over 3,000 customers worldwide manage their business performance and respond to the marketplace in real time.

    Some of Applix’s customers include: Aventis, Bristol-Myers Squibb, Pfizer, Biovail, MedImmunue and Schering-Plough.

      George Foldes, Senior Business Analyst, Aspreva Pharmaceuticals

    George Foldes has more than 30 years experience in pharmaceutical sales, marketing, market research, business development, key account management and market access.

    As Manager Business Analytics and Forecasting at Aspreva Pharmaceuticals Corporation, Mr Foldes is responsible for sales tracking, developing forecasts for emerging markets and evaluating new business opportunities on a global scale.  He is also developing and implementing new structures and processes for assumption-based forecasting and competitive intelligence.

    Aspreva Pharmaceuticals identifies, develops and commercializes new applications for existing medicines anticipated to have high therapeutic value for underserved diseases – diseases in which there is a lack of adequate treatment options and few if any treatments in development.  Through an innovative partnering approach, Aspreva enables its partners to maintain focus on core indications while maximizing brand assets.


    Christopher-Paul Milne, D.V.M., M.P.H., J.D.,
    Associate Director, Tufts Center For The Study Of Drug Development

    Formerly a practicing veterinarian in New Jersey and Maryland, Dr. Milne also attended Johns Hopkins University where he earned a master’s degree in public health with a concentration in epidemiology and health statistics. For six years, he worked for the New Jersey Department of Health, initially as a researcher in health risk assessment, later in legislative and regulatory review as Manager of the Public Response Program, and finally as Emergency Response Coordinator. In 1997, Dr. Milne graduated from law school at the Franklin Pierce Law Center in Concord, New Hampshire, where he studied environmental and health law.

    Dr. Milne joined the Center in 1998 as a Senior Research Fellow in order to address legal and regulatory issues that affect the research and development of new drugs and biologicals. His current research interests include: challenges to the R&D of new medicines; the role of outsourcing in drug development; incentive programs for pediatric studies; issues related to the R&D of treatments for serious and life–threatening illnesses (fast track diseases), rare disorders and conditions (orphan diseases), and neglected diseases of the developing world; and, trends in FDA and EMEA regulatory and policy initiatives related to the Critical Path Initiative, EMEA Road Map 2010, postmarketing commitments (PMCs), and pharmacogenomic data. Dr. Milne has lectured and published widely on these topics. Dr. Milne is currently Associate Director of the Tufts CSDD and a licensed attorney.

    Tim Knutson, Area Manager, Applix

    Tim Knutson is an Area Manager with Applix and the host of the webinar event. Tim is responsible for working with Applix’s Pharmaceutical and Biotech customers from the West Coast to the Midwest regions of the United States. Some of Tim’s customer accounts include Amgen, MannKind and Theravance. Tim has over 15 years of experience in working with companies on their Business Performance Management process improvements, as well as compliance.
    For information about the recorded archive for this event contact Xtalks at (416) 977-6555 ext 371, or email
    Copyright © 2016-2017 Honeycomb Worldwide Inc.